So far, no genetic changes including mutation, deletion, and gene rearrangement of DSC3 have been found in cancer, and except for the detailed description of methylation patterns in breast cancer, no methylation analysis of DSC3 in any other tumour entity has been reported. This evidence concerns the gene DSC3 and breast carcinoma.